Literature DB >> 2554802

In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

D F Sahm1, J Kissinger, M S Gilmore, P R Murray, R Mulder, J Solliday, B Clarke.   

Abstract

Vancomycin resistance exhibited by Enterococcus faecalis isolates V583, V586, and V587 is described. The vancomycin MICs ranged from 32 to 64 micrograms/ml. Although resistant to vancomycin, the isolates were susceptible to teicoplanin (MIC, less than or equal to 0.5 micrograms/ml). Such a glycopeptide susceptibility profile has not been previously described for E. faecalis. Time kill studies showed that vancomycin resistance adversely affected the synergistic activity that vancomycin and aminoglycoside combinations usually demonstrate against enterococci. However, the ability to detect vancomycin resistance varied with the susceptibility testing method used. Whereas broth microdilution, broth macrodilution, and agar dilution methods detected resistance, disk-agar diffusion and the AutoMicrobic system Gram-Positive GPS-A susceptibility card (Vitek Systems Inc., Hazelwood, Mo.) did not. To detect vancomycin resistance reliably and establish the incidence of such E. faecalis isolates, adjustments in some susceptibility testing methods may be necessary.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554802      PMCID: PMC172707          DOI: 10.1128/AAC.33.9.1588

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

2.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

3.  In vitro activity of LY146032 against staphylococci, streptococci, and enterococci.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

5.  Vancomycin-streptomycin synergism in enterococcal endocarditis.

Authors:  G O Westenfelder; P Y Paterson; B E Reisberg; G M Carlson
Journal:  JAMA       Date:  1973-01-01       Impact factor: 56.272

6.  In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; C Thauvin; B Gerson; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

7.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

8.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

Authors:  F Parenti; G Beretta; M Berti; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

9.  In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.

Authors:  H J Harwick; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

10.  Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.

Authors:  C Watanakunakorn; C Bakie
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

View more
  247 in total

1.  The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods.

Authors:  Jasmine M Chaitram; Laura A Jevitt; Sara Lary; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors:  Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 3.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci.

Authors:  K H Dahl; G S Simonsen; O Olsvik; A Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

Authors:  Florence Depardieu; Mathias Kolbert; Hendrik Pruul; Jan Bell; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Growth rate-dependent control in Enterococcus faecalis: effects on the transcriptome and proteome, and strong regulation of lactate dehydrogenase.

Authors:  Ibrahim Mehmeti; Ellen M Faergestad; Martijn Bekker; Lars Snipen; Ingolf F Nes; Helge Holo
Journal:  Appl Environ Microbiol       Date:  2011-10-28       Impact factor: 4.792

Review 7.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 8.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

9.  In vitro detection of enterococcal vancomycin resistance.

Authors:  D F Sahm; L Olsen
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

10.  Construction of an Enterococcus faecalis Tn917-mediated-gene-disruption library offers insight into Tn917 insertion patterns.

Authors:  Danielle A Garsin; Jonathan Urbach; Jose C Huguet-Tapia; Joseph E Peters; Frederick M Ausubel
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.